BIO

Bio-Rad Laboratories, Inc.
$369.95
+6.45 (+1.77%)
Mkt Cap 9.89B
Volume 167,405
52W Range 236.73-396.23
Sector Healthcare
Beta 1.07
EPS (TTM) 8.33 USD
P/E Ratio 44.41
Revenue (TTM) 2.59B USD
Rev Growth (5Y) +0.3%
EPS Growth (5Y) -26.3%
AlphaVal · Fair Value
What we estimate one share is worth
$418.05
Fair Value weak signal
11.5% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 2.58B 2.57B 2.67B 2.80B 2.92B 2.55B 2.31B 2.29B 2.16B 2.07B 2.02B 2.18B
Net Income 759.90M (1.84B) (637.32M) (3.63B) 4.25B 3.81B 1.76B 361.00M 114.74M 28.12M 113.09M 88.84M
EPS 27.87 -65.36 -21.82 -121.79 142.61 127.86 58.93 12.10 4.12 0.88 3.74 3.08
Free Cash Flow 374.60M 266.20M 218.26M 80.29M 535.72M 476.41M 359.37M 155.67M (10.99M) 74.50M 72.84M 136.83M
FCF / Share 13.74 9.44 7.47 2.70 17.96 16.00 12.04 5.22 -0.37 2.53 2.50 4.74
Operating CF 532.20M 455.20M 374.94M 194.45M 669.46M 584.97M 457.90M 285.49M 104.14M 216.07M 186.21M 273.31M
Total Assets 10.58B 9.36B 12.30B 13.50B 17.80B 12.97B 8.01B 5.61B 4.27B 3.85B 3.71B 3.34B
Total Debt 1.53B 1.37B 1.41B 1.39B 223.38M 225.74M 651.18M 439.43M 435.00M 434.52M 434.18M 435.98M
Cash & Equiv 531.80M 488.10M 403.80M 434.21M 470.78M 662.21M 660.67M 431.53M 383.82M 456.26M 457.55M 413.25M
Book Value 7.45B 6.57B 8.74B 9.62B 13.69B 9.88B 5.76B 4.02B 2.93B 2.58B 2.49B 2.19B
Return on Equity 0.10 -0.28 -0.07 -0.38 0.31 0.39 0.31 0.09 0.04 0.01 0.05 0.04
BIO News
BIO-key Secures Another Middle East Government Contract for its Passwordless, Biometric, Identity and Access Management Solutions
Oct 21, 2026 11:59 PM · globenewswire.com
Bio-Rad Laboratories Inc (BIO) Stock Down 3.0% but Still Overvalued -- GF Score: 73/100
Oct 16, 2026 02:43 PM · gurufocus.com
Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
Oct 14, 2026 05:00 AM · businesswire.com
BIO-key Names Cybersecurity Veteran Stephen Morrow President of PortalGuard to Drive Accelerated Adoption of its Innovative IAM Solution
Oct 13, 2026 04:29 AM · globenewswire.com
BIO-key Adds New Middle East Government Security Agency Customer, Expanding Regional Footprint
Oct 13, 2026 12:01 AM · globenewswire.com
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
Oct 07, 2026 04:48 AM · globenewswire.com
PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026
Oct 05, 2026 04:00 AM · globenewswire.com
BIO-key Partners with Al Majlis Group to Expand Identity Security Across Arabian Gulf
Sep 28, 2026 11:30 PM · globenewswire.com
Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth
Sep 25, 2026 07:02 PM · marketbeat.com
Bio-Rad Laboratories, Inc. (BIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
Sep 24, 2026 09:09 AM · seekingalpha.com